Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_assertion type Assertion NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_head.
- NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_assertion description "[Antibodies against CAGE protein were detected in approximately 5.1% of the sera from HCC patients, 8.3% of that from gastric cancer patients and 7.3% of that from colorectal cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_provenance.
- NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_assertion evidence source_evidence_literature NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_provenance.
- NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_assertion SIO_000772 15756260 NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_provenance.
- NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_assertion wasDerivedFrom befree-2016 NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_provenance.
- NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_assertion wasGeneratedBy ECO_0000203 NP484826.RAEtP9ncMv6nW9qSUpRlNHvtq96M_4bO0V2QNnq-vUiGI130_provenance.